Jonathan Dalla‐Riva

Lund University — Sweden

Medicine · Health Sciences

8h-index262citations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(6), Lipoproteins and Cardiovascular Health(4), Metabolism, Diabetes, and Cancer(4), Diabetes Treatment and Management(3), Pancreatic function and diabetes(2)

Publications18 total

Genomic editing of metformin efficacy-associated genetic variants in <i>SLC47A1</i> does not alter <i>SLC47A1</i> expression
Human Molecular Genetics·2021· 4 citedOpen Access
Anti‐ApoA‐I IgG antibodies are not associated with carotid artery disease progression and first‐time cardiovascular events in middle‐aged individuals
Journal of Internal Medicine·2018· 6 cited
Genome editing (CRISPR-Cas9) to identify and characterise functional variants determining metformin response
Diabetologie und Stoffwechsel·2018· 2 cited
The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden: the GLACIER Study
International Journal of Obesity·2018· 18 citedOpen Access
Gene-diet interaction analysis, fine mapping and genomic annotation of the FADS1-2-3 gene cluster reveals regulatory potential in diabetes
Diabetologia·2017
Glycation of ApoA-I links diabetes and CVD
Atherosclerosis·2016
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
PLoS ONE·2015· 16 citedOpen Access
ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation
Journal of Lipid Research·2015· 25 citedOpen Access
A structural and functional approach to elucidate the linkage of the apoA-I A164S variant to increased risk of cardiovascular disease
Atherosclerosis·2015
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility
PLoS ONE·2014· 24 citedOpen Access
Decreased functionality of A164S variant of apolipoprotein A‐I in cardiovascular disease (1002.1)
The FASEB Journal·2014
Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism
Metabolism·2014· 26 cited
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice
Diabetologia·2014· 70 citedOpen Access
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle
Journal of Lipid Research·2013· 55 citedOpen Access
Influence of Lipid Content and Oxidation State of Chylomicron Remnants on Endothelial Cell Signalling And Function
Atherosclerosis Supplements·2010
Endothelial cells as targets for chylomicron remnants
Atherosclerosis Supplements·2010· 16 citedOpen Access
Potential cytoprotective effects of chylomicron remnants in vascular cells
Atherosclerosis Supplements·2008
Protective responses of human endothelial cells to n−6 PUFA-containing chylomicron remnants are independent of particle oxidative state
Chemistry and Physics of Lipids·2008

Frequent Co-authors

Jens O. Lagerstedt(10), Jitka Petrlová(8), Maria Lindahl(5), Karin G. Stenkula(4), Kathleen M. Botham(4), Caroline Wheeler‐Jones(4), Ewa Krupinska(3), Maria Keller(3), Azra Kurbasic(3), Paul W. Franks(3), Olga Göransson(2), Helena A. Jones(2), Joan Domingo‐Espín(2), Angela C. Estampador(2), Alaitz Poveda(2), Frida Renström(2), Tibor V. Varga(2), Elena Garonna(2), Jonathan Elliott(2), Katja Bernfur(2)